|Bid||29.00 x 800|
|Ask||35.77 x 900|
|Day's Range||29.50 - 29.92|
|52 Week Range||28.75 - 42.45|
|Beta (5Y Monthly)||0.98|
|PE Ratio (TTM)||16.89|
|Forward Dividend & Yield||0.71 (2.43%)|
|Ex-Dividend Date||May 13, 2022|
|1y Target Est||N/A|
HONG KONG, May 12, 2022--Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, today announced its global ‘United in Care’ campaign that celebrates the diversity, unity and positive impact of its nurses and clinical teams across Asia Pacific, Europe, the Middle East and Africa, North America and Latin America.
Fresenius Medical Care, the world's leading provider of products and services for people with advanced kidney disease, announced today that the company's Global Medical Office has launched the My Reason® campaign to promote patient enrollment in the company's kidney-focused genomics registry which was first introduced last year.
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, announced today the appointment of noted clinical researcher and nephrologist Nwamaka (Amaka) Eneanya, MD as Head of Strategy and Operations for the company's Global Medical Office.